Rheumatoid arthritis is a chronic autoimmune disorder that primarily affects the joints, causing inflammation, pain, and swelling. Over time, this inflammation can lead to joint damage and deformities, making daily activities difficult for those affected.

Recent advances in understanding the immune pathways involved in rheumatoid arthritis have led to the development of more targeted therapies, aiming to reduce inflammation and slow disease progression. These therapies focus not only on symptom relief but also on addressing the underlying causes of joint damage and systemic inflammation.

iNGENū's team of researchers and clinicians is dedicated to advancing rheumatoid arthritis research. By leveraging innovative trial designs and a patient-centered approach, we aim to accelerate the development of new treatments that have the potential to improve the quality of life for those living with rheumatoid arthritis.